SU11274, CAS [[658084-23-2]]

Produktübersicht

• Artikelname: SU11274, CAS [[658084-23-2]]
• Artikelnummer: BYT-ORB1301028
• Hersteller Artikelnummer: orb1301028
• Alternativnummer: BYT-ORB1301028-1,BYT-ORB1301028-2,BYT-ORB1301028-5,BYT-ORB1301028-10,BYT-ORB1301028-25,BYT-ORB1301028-50,BYT-ORB1301028-100
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: CDK2, c-Met/HGFR, cMet, c-Met, cMet/HGFR, Autophagy, Apoptosis, Met, Met Kinase Inhibitor, HGFR, Flk1, FGFR1, PKI-SU 11274, PKI-SU11274, PKI-SU-11274, RON, SU11274, SU-11274, SU 11274

Produktbeschreibung

SU11274 is a potent and selective Met kinase inhibitor with an IC50 of 10 nM. It demonstrates minimal activity against related kinases such as PGDFRbeta, EGFR, and Tie2. This inhibitor is widely used in cancer research for in vitro and in vivo studies investigating Met-driven tumorigenesis and metastasis.

Produkteigenschaften

• Molekulargewicht: 568.09
• Reinheit: 99.53% (May vary between batches)
• CAS Nummer: [658084-23-2]
• Formel: C28H30ClN5O4S
• Target-Kategorie: FGFR,c-Met/HGFR,VEGFR,Apoptosis,Autophagy,CDK

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: H2O:< 1 mg/mL (insoluble or slightly soluble),10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (5.81 mM),Ethanol:2 mg/mL (3.52 mM),DMSO:48.33 mg/mL (85.07 mM)